BeOne Medicines
ONC
#636
Rank
S$49.41 B
Marketcap
S$446.59
Share price
-1.23%
Change (1 day)
62.53%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: S$49.41 Billion

As of January 2026 BeOne Medicines has a market cap of S$49.41 Billion. This makes BeOne Medicines the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026S$49.41 B11.35%
2025S$44.38 B59.43%
2024S$27.83 B6.92%
2023S$26.03 B-23.64%
2022S$34.09 B-9.25%
2021S$37.57 B19.99%
2020S$31.31 B127.31%
2019S$13.77 B20.65%
2018S$11.41 B91.81%
2017S$5.95 B241.41%
2016S$1.74 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of BeOne Medicines was reported to be:

S$49.41 Billion
by Nasdaq info icon info icon
S$49.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
S$26.92 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
S$1.32 B-97.31%๐Ÿ‡บ๐Ÿ‡ธ USA